T lymphocytes are components of the immune system that are located in the tumor environment. They serve to identify and remove tumor cells. In order to perform this function, they must produce a large amount of secreted proteins, ...
Mar 28, 2023
0
3
A new review paper titled "What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's prognostic ability in different cancer types" has been published in Oncotarget
Mar 6, 2023
0
5
Next-generation sequencing studies have in recent years revealed numerous recurrently mutated genes in chronic lymphocytic leukemia (CLL). These mutations are usually found in a relatively small percentage of cases and associated ...
Mar 3, 2023
0
86
Researchers from Japan have found that white blood cells, known as B lymphocytes, have a pivotal role in promoting an emergent response to stimulate the in-demand production of innate immune cells during an infection.
Feb 15, 2023
0
19
A tough battle requires endurance. This is also true for white blood cells as they tackle cancer—or more specifically for T lymphocytes or T cells, a group of white blood cells involved in the immune system's fight against ...
Feb 2, 2023
0
34
The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Jan 24, 2023
0
3
Technology that enables an unprecedented, high-resolution look for all structural variants in our genes that are known to cause cancer can outperform standard tests used today for common blood cancers like leukemia, researchers ...
Jan 17, 2023
0
57
The SARS-CoV-2 delta variant that caused the third wave of COVID-19 in mid-2021 turned out to be more contagious than earlier SARS-CoV-2 variants. In addition, protein mutations in the delta variant were found to significantly ...
Jan 17, 2023
0
43
Every year, up to 1% of patients with chronic lymphocytic leukemia (CLL), a slow-growing blood cancer, have their disease transform into a far more aggressive cancer, a form of lymphoma known as Richter's syndrome. For the ...
Dec 12, 2022
0
61
Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose ...
Dec 11, 2022
0
59
